TrialDiabetes2023

Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes.

Elaine Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.